Off-Label Use of Cancer Drugs: A Benchmark Is Established

被引:14
|
作者
Krzyzanowska, Monika K. [1 ,2 ,3 ]
机构
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
关键词
BEVACIZUMAB; THERAPY; SAFETY;
D O I
10.1200/JCO.2012.46.9460
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1125 / 1127
页数:3
相关论文
共 50 条
  • [41] Off-Label Prescriptions in Dermatology: Challenges of New Routes of Administration for Certain Old Drugs
    Tasic-Kostov, Marija
    Ilic, Dusan
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2020, 37 (02) : 131 - 138
  • [42] Extent and patterns of off-label use of rituximab for SLE
    Sanz, Inaki
    Nature Reviews Rheumatology, 2016, 12 (12) : 700 - U23
  • [43] Off-label use of medicines in South Africa: a review
    Ngcobo, N. N.
    Mathibe, L. J.
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [45] Off-label Use of Azathioprine in Dermatology A Systematic Review
    Schram, Mandy E.
    Borgonjen, Rinke J.
    Bik, Cathelijne M. J. M.
    van der Schroeff, Jan G.
    van Everdingen, Jannes J. E.
    Spuls, Phyllis I.
    ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 474 - 488
  • [46] Prospective data collection of off-label use of rituximab in Australian public hospitals
    O'Connor, K.
    Liddle, C.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (08) : 863 - 870
  • [47] Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study
    Joerger, M.
    Schaer-Thuer, C.
    Koeberle, D.
    Matter-Walstra, K.
    Gibbons-Marsico, J.
    Diem, S.
    Thuerlimann, B.
    Cerny, T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (06) : 719 - 725
  • [48] Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS Versus the US Justice Department
    Curtiss, Frederic R.
    Fairman, Kathleen A.
    JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (02): : 161 - 165
  • [49] Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review
    Yang, Benyu
    Li, Wenhan
    Gao, Yiqiang
    Zhang, Bo
    Zuo, Wei
    BIOMEDICINES, 2024, 12 (11)
  • [50] Pertinence of Off-label Prescriptions of Innovating and Expensive Drugs in a University Hospital
    Falabregues, Amelie
    Daul, Marion
    Pourroy, Bertrand
    Gauthier-Villano, Laurence
    Pisano, Pascale
    Rathelot, Pascal
    Vialettes, Bernard
    THERAPIE, 2015, 70 (05): : 385 - 402